Floatz logo

METHADONE

Chronic Neuropathic Pain

Nova Scotia Health AuthoritySmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Chronic Neuropathic Pain cohort.

Asset / SponsorPhaseRating
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Boston Children's Hospital
Phase 4BB
Amitriptyline
UMC Utrecht
Phase 4BB
NEPENTHE
Nova Scotia Health Authority
Phase 4BB
Naltrexone
Emory University
Phase 4BB
FENTANYL
Cephalon
Phase 3B

View all 10 →

Same molecule, other indications

METHADONE is also rated in:

substance-related disorderDormant
BBB
Indicative ·
78 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Opiate AddictionDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →